COPD

The AJMC® COPD compendium is a comprehensive resource for clinical news and expert insights for chronic obstructive pulmonary disease.

Latest News

COPD illustration | Image Credit: peterschreiber.media - stock.adobe.com
Ineligibility, Limitations to PR Uptake in Patients With AECOPD

October 15th 2024

Two posters at the CHEST 2024 annual meeting revealed that 18% of eligible patients hospitalized with acute exacerbations of chronic obstructive pulmonary disease (AECOPD) participated in post-discharge pulmonary rehabilitation (PR), with ineligibility significantly limiting uptake.

Definition of opioids | Image Credit: Feng Yu - stock.adobe.com
Opioids, Benzodiazepines Linked to Higher Mortality in Older Patients With COPD

September 30th 2024

FDA approval stamp | Image Credit: cartoon - stock.adobe.com
FDA Approves Dupilumab as First Biologic Treatment for COPD

September 27th 2024

Man reaching for cigarette | Image Credit: Nopphon - stock.adobe.com
COPD Poses Public Health Risk for US Smokers, Nonsmokers

September 26th 2024

AJMC
COPD Treatment Ratio: A Measure for Improving COPD Population Health

September 18th 2024

Type 2 Inflammation: A Common Theme Among Several Chronic Diseases

Learn about the multifaceted aspects of type 2 inflammatory diseases, including impact on quality of life; the role of biomarkers in diagnosis and treatment selection; and unmet needs in clinical management.

Learn about the multifaceted aspects of type 2 inflammatory diseases, including impact on quality of life; the role of biomarkers in diagnosis and treatment selection; and unmet needs in clinical management.

More News

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo